Fusion Pharmaceuticals Inc. Accrued Professional Fees, Current
Fusion Pharmaceuticals Inc. had Accrued Professional Fees, Current of $6.51 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedProfessionalFeesCurrent · last filed 2024-05-07
- 2024-03-31: Accrued Professional Fees, Current $6.51M.
- 2023-12-31: Accrued Professional Fees, Current $899.00K.
- 2023-09-30: Accrued Professional Fees, Current $755.00K.
- 2023-06-30: Accrued Professional Fees, Current $1.14M.
| Period end | Accrued Professional Fees, Current | Accrued Professional Fees, Current as first filed |
|---|---|---|
| 2024-03-31 | $6.51M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $899.00K 10-Q · filed 2024-05-07 | |
| 2023-09-30 | $755.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.14M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.78M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $916.00K 10-K · filed 2024-03-20 | |
| 2022-09-30 | $1.12M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $998.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.11M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $627.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $1.11M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $825.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $788.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $1.02M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $1.05M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $791.00K 10-Q · filed 2020-08-11 | |
| 2019-12-31 | $744.00K 10-K · filed 2021-03-25 | $641.00K 10-Q · filed 2020-08-11 |